| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |